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Summary 
We have studied the consequences of invariant chain (Ii) and DM expression on major histo- 
compatibility complex (MHC) class II function. I1 has a number of discrete functions in the bi- 
ology of class II, including competitive blocking of peptide binding in the endoplasmic reticu- 
lum and enhancing localization in the endocytic compartments. DM is thought to act primarily 
in endosomes to promote dissociation of the Ii-derived (CL1P) peptide from the class II anti- 
gen-bindmg pocket and subsequent peptide loading. In this study, we have evaluated the func- 
tional role of Ii and DM by examining their impact on surface expression of epitopes recognized 
by a large panel o£ aUoreactive T  cells. We find most epitopes studied are influenced by both Ii 
and DM.  Most strikingly, we find that surface expression of a significant fraction of peptide- 
class II complexes is extinguished, rather than enhanced, by DM expression within the APC. 
The epitopes antagonized by DM do not appear to be specific for CLIP. Finally, we found that 
DM was also able to extinguish recognition of a defined peptide derived from the internally syn- 
thesized H-2L  d protein. Thus, rather than primarily serving in the removal of CLIP, DM may 
have a more generalized function of editing the array of peptides that are presented by class II. 
This editing can be either positive or negative, suggesting that DM plays a specifying role in the 
display ofpeptldes presented to CD4 T  cells. 
I 
nvariant chain (Ii) and the newly described DM proteins 
(H-2M in the mouse,  hereafter referred to as DM)  are 
critical for MHC  class II-restncted  antigen  presentation. 
They function by regulating several key intracellular events 
in class II biogenesis (reviewed in references 1-4). Binding 
of Ii  to  class  II  molecules  in  the  endoplasmic  reticulum 
competitively blocks peptlde binding  (5,  6)  and facilitates 
egress  into Golgi compartments (7-9). Later in biosynthe- 
sis, Ii enhances class II localization in endosomal compart- 
ments (10-12). Here, DM resides and functions in the class 
II pathway (13).  Cells lacking DM have been shown to be 
severely compromised in their presentation  of exogenous 
antigens and to have low levels of SDS-stable dimers. Class 
II molecules isolated from these DM-deficient cells are pre- 
dominately occupied by the  class II-associated Ii peptide 
(CLIP) 1. Transfection of genes encoding DM corrects these 
phenotypic characteristics  (14-16).  Most recently, the func- 
tion of DM has  been probed by biochemical means  (17- 
19).  These  studies  indicate  that  coincubation  of purified 
DM and class II molecules leads  to greatly enhanced rates 
of CLIP release and peptide loading.  Recent data suggest 
I  Abbrevtatwn used m this paper" CLIP, class lI-assooated  h pepnde. 
that  these  effects likely involve direct interaction of DM 
with the class II restriction element (20). 
Despite our increasing appreciation of the mechanism by 
which  DM  functions,  the  functional  consequences  of its 
expression within APC are incompletely understood. Un- 
like  the  situation  in  biochemical  experiments,  in  which 
peptlde, MHC molecule, and DM can be incubated for ex- 
tended  periods  of time  under  carefully regulated  condi- 
tions, in a live APC the interactions among these molecules 
and the consequences of thmr interaction will depend only 
partially on their ability to colocalize. The milieu in which 
they interact and the time frame of their colocalization will 
determine the biological effects of their coexpression within 
an APC. In this study, we have examined the immunologic 
consequences of Ii and DM  expression within APCs  and 
have focused on presentation ofpeptides derived from pro- 
teins synthesized within the cell, because these occupy the 
majority of class II molecules on the APC (21,  22) and be- 
cause of their importance in T cell development, tumor an- 
tigen presentation, and in autoimmunity. Data from our lab- 
oratory (23) and others  (24-27)  suggest  that  there  may be 
distinct pathways  used  for the  presentation of exogenous 
and endogenous antigens (reviewed in reference 28). In the 
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H-2L  a presented in the context of I-A  d and a large panel of 
individual alloreactive T  cell clones as probes for self-pep- 
tide-class II complexes. Our experiments and those of oth- 
ers suggest that the specificity of alloreactive T  cells is dic- 
tated by the peptides bound by the  class II molecule  (29, 
30).  Our  own  data suggest that  these peptides derive pri- 
marily from an  endogenous  source  (29).  The  experiments 
presented here suggest that Ii and DM  can profoundly af- 
fect the array ofpeptides presented by the class II molecule 
I-A  a.  While Ii generally enhances  antigen presentation by 
the class II molecule, we show here the first demonstration 
that DM  can dramatically reduce cell surface expression of 
particular peptide-class II complexes. Our data shows DM 
function  is not  restricted to  CLIP  removal.  Within APC, 
this protein serves to positively or negatively edit the array 
of antigenic peptides presented to the immune system. 
Materials and Methods 
Mice.  BALB/c and C57BL/6  females  (12-16  weeks of age) 
were purchased from the Jackson Laboratories (Bar Harbor, ME). 
B10.GD mice were produced by Blocore (Frederick, Maryland) 
and were kindly provided by Dr. Jay Berzofsky. 
Tissue Culture Reagents.  Cells lines were maintained in Dul- 
becco's MEM supplemented with 5% FCS (HyClone Laborato- 
ries,  Logan, UT),  supplemented as described (23).  Transfectants 
were supplemented with selection drugs G418 (0.2 mg/rrd) and/or 
Blastiodm  (2  p~g/ml).  Media and  supplements were  purchased 
from Gibco Laboratories (Grand Island, NY) unless otherwise noted. 
Cell Lines and Transfectants.  Ltk- cells were transfected by cal- 
cium phosphate with I-A  d ct and 13 chain cDNAs plus the neo- 
mycin  resistance  gene.  MHC  class  II-posltlVe cells  were  sub- 
cloned and then supertransfected with the genes encoding murlne 
gli, provided by Dr. Jim Miller (University of Chlcago) or mu- 
fine DM  o~ and  [3 chain cDNA genes, kindly provided by Dr. 
John Monaco (University of Cincinnati). The cDNA constructs 
were  cloned into  the  SV40  based vector pcEXV-3.  Secondary 
transfection and drug selection was done using the pSV2bsr2 gene 
(31) and the antibiotic blasticldln (ICN, Costa Mesa, CA). Trans- 
fected cells were stained for class II expression every 3-6 weeks 
durmg this analysis, and typically varied less than twofold m  cell 
surface density of class II molecules. 
mAbs and bnmunofluorescence Staining.  Hybrldomas producing the 
mAbs M5114 and MKD6 were obtained from ATCC. Cell lines 
were stained in a two-step procedure, previously described (32), 
and analyzed on a FACScan  ® cytofluorimeter (Becton Dickinson, 
Mountain View, CA). 
T  Cell Hybridomas.  Alloreactlve Ad-restricted T  cell hybndo- 
mas were prepared from  C57BL/6  mice primed with BALB/c 
spleen cells,  as previously described (29).  In brief, T  cells from 
primed animals were restimulated in vitro with irradiated BALB/c 
spleen cells and then fused with the T  cell receptor cx13 negative 
variant of BW5147. Hybridomas were subcloned by limiting ddu- 
non and selected by growth in HAT medium and for reactivity on 
BALB/c spleen. Spleen-reactive T cells were then analyzed for A a 
reactivity using L cell transfectants  or B10.GD (A  a+, E a-) spleen. 
The BC7 hybridoma, which is specific for the L  d pepude 61-85 
presented in the context of I-A  d, has previously been described (23). 
T  Cell Hybridoma  Assays.  APCs were removed from selective 
drug for 48 h and plated in 200 Ixl m flat-bottomed 96-well plates 
at 5  ×  104  cells/well with 5  X  104 T  cells. After coculture for 
16-20 h, supernatant was tested for IL-2, using either an ELISA 
assay or by measuring proliferatmn of CTLL with munne IL-2 used 
as a control. Results are scored as picograms per mdlihter of IL-2. 
Western Blot Analysis.  Class II molecules isolated from the L cell 
transfectants by immunopreclpitation with MKD6-protein A-Seph- 
arose were eluted in 1.0% SDS, 10% glycerol, and 0.0625 M Trls, 
pH 6.8, at RT for 30 min, and one-half was boiled for 5 mm at 
100°C  while the other remained at room temperature.  Proteins 
were then fractlonated by SDS-10%-PAGE and were transferred 
onto mtrocellulose membranes and analyzed by Western blotting 
as we have previously described (33). 
Results and Discussion 
To  examine the functional consequences  of Ii and DM 
expression  within  APC,  we  used  a  murine  transfectlon 
model in which the original recipient cell was negative for 
expression ofIi, DM, and class II molecules, but that would 
interact productively with  T  cells upon  expression of the 
class II restriction dement. In previous expenments (29), we 
tested a panel of such APCs and found that of the murine 
cell lines tested,  Ltk  cells were  able  to  activate  antigen- 
specific T  cells most effectively, with an efficiency close to 
that displayed by a lymphoblastoid B  cell line. These Ltk- 
cells lack detectable expression of Ii and did not express any 
DM  u  chain  mRNA,  although  a  small amount  of the  [3 
chain  mILNA  is  made.  Studies  involving mutant  human 
cells have  shown  that the single chains do not yield func- 
tional DM  (14,  15).  Thus,  the Ltk- cells were chosen as a 
transfection  recipient.  Cells  were  sequentially  transfected 
with  genes  encoding  murine  class  II,  murine  Ii,  and/or 
routine DM  oL and  [3 chains using two  different dominant 
selectable markers. 
Fig.  1 shows a representative analysis of the gene expres- 
sion of the four cells used in the functional studies (A  d [I- 
A d, a  and [3 alone], A°-Ii [I-A  a ~  and [3 with Ill, Ad-DM 
[A  a a  and [3 with DM o~ and [3], and Ad-Ii-DM [A  a t~ and 
[3 with both DM  and Ii constructs]). MHC  class II surface 
expression was measured by mAb staining and flow cytom- 
etry  (Fig.  1  A).  Ii  expression  was  measured  by  Western 
blotting  (/3) and  DM  expression  was  measured  by  PCR 
amplification ofDM  oL and DM 13 cDNA (C). Our experi- 
ments indicate that cell surface expression of class II mole- 
cules is comparable among the transfectants,  and that cells 
transfected with genes encoding Ii and DM  in addition to 
A a express similar levels of these protein cofactors. 
An analysis of the  effects  of Ii and  DM  on  SDS-stable 
dimer expression, which  reflects stable peptide binding to 
class II molecules (34~36), is shown in Fig. 2. These exper- 
iments revealed that neither Ii nor DM  alone has any sig- 
nificant  effect  on  the  ability of I-A  d  to  form  SDS-stable 
dimers.  When  expressed together,  they allow a significant 
fraction  of class  II  molecules within  the  fibroblast line  to 
stably bind peptide. The ability of DM to facilitate conver- 
sion of I-A  ° to an SDS-stable form in the presence of Ii is 
associated with  removal  of CLIP  (data  not  shown).  The 
primary biochemical effect of h  detected in our system is an 
increase in the relative abundance  of mature class II mole- 
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Figure  1.  (A)  Flow cytometry analysis of surface I-A  a expression  on 
Ltk  transfectants. L cells expressing I-A  d alone,  I-A  d plus h  chain,  I-A  d 
plus DM, or I-A  a plus h  and DM were stained with  14.4.4S 0rrelevant 
antl-l-E  mAb)  and  fluorescem  goat  anti-mouse  Ig  (GAM)  or  MKD6 
(anti-l-A  a)  and  GAM. Flow cytometry profiles obtained  wath 14-4S or 
MKD6 are indicated  by GAM or MKD6 in the figure.  In the course  of 
these expenments,  APCs were stained periodically for class II surface ex- 
pression. Although in the experiment shown here,  h-posltwe cells were 
threefold brighter  than  cells lacking Ii, the same T cell activation patterns 
described in Fig. 3 were observed for cells that were matched  for class II 
surface expression.  (B) Western blot analysis of h  expression in transfec- 
tants  MKD6 (antl-I-A  a) lmmunoprecipitates  prepared from detergent ly- 
sates of the cell expressing the genes indicated above each lane were frac- 
tionated  by SDS-PAGE and analyzed for the presence  of h  by Western 
blots using the antibody  In-1. Shown are h p31 and p41 protein products. 
(C) PCP,. quantitation  of DMot and DM[3 cDNA expression, cDNA was 
prepared  from the L cell transfectants and amplified by PCR using prim- 
ers specific for DM cx or DM 13. Because the Ltk  cells  express a low level 
of DM13 chain,  the  5'  pnmer for 13  corresponds  to  a sequence  in  the 
pcEXV expression vector.  Pnmers for actln cDNA (at the bottom of the 
gel) were included  as a control for the cDNA and the PCI:k amphficatlon 
steps. 
cules,  as  detected  by  their  increase  in  apparent  molecular 
weight on the SDS-PAGE  gels.  It has been shown  that  this 
effect is due to the ability of Ii to facilitate export of class II 
molecules from the ElL to cis-Golg-a  (1,  2,  6).  Thus,  several 
of the  biochemical hallmarks  of DM  and  Ii expression  are 
detectable in our model system. 
Fig. 3  shows the consequences  of li and DM  on the cell 
surface  expression  of peptide--class  II  complexes.  A  large 
panel  of anti-I-A  a alloreactive T  cell hybridomas  was  gen- 
erated  and  analyzed  in  detail  for  their  ability  to  recognize 
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Figure  2.  SDS-stable dlmer formation  m  L cell transfectants depends 
on I1 and DM. L cell transfectants expressing the genes shown m the fig- 
ure were solubfllzed m  CHAPS and lmmunopreclpitated  with the anti- 
class  II  mAb  MKD6.  Immunoprecipltates  were  eluted  in  SDS  sample 
buffer and split into two equal ahquots  Half of the sample was boiled for 
5  rain,  while the other was malntamed  at  room temperature.  Proteins 
were fractionated by SDS-PAGE and probed for the class II [3 chain using 
the mAb M5114  The mobflltaes  of SDS-stable dimer and the free [3 chain 
are indicated by arrows. 
the panel oftransfectants.  T  cell activation was measured by 
IL-2 production  and data  are presented  as picograms/ml of 
IL-2.  A  summary  of the reactivity patterns  detected is pre- 
sented  in  Fig.  3,  which  also  shows  the  number  of T  cells 
that  belonged  to  a  particular  reactivity pattern  with exam- 
ples of the primary data from representauve  T  cells in each 
group. 
A  surprising degree of complexity in the functional con- 
sequences  of DM  and  Ii  expression  was  revealed  by  this 
analysis  and  several  unexpected  findings  were  made.  The 
vast majority of alloreactive T  cells' reactivity is modulated 
both by Ii and  DM.  Most striking was the finding that  the 
proportion  of T  cells  whose  reactivity  was  enhanced  by 
DM  (groups  A  and  D)  equaled  the  proportion  of T  cells 
whose  reactivity  was  diminished  or  extinguished  by  DM 
expression  (groups  B  and  E).  The  functional  studies  per- 
formed  thus  far by  our  group  (33)  and  others  (14,  37-40) 
involving analyses  of exogenous  antigen  presentation  have 
revealed either  a  neutral  or  positive  effect of DM  expres- 
sion  on  epitope  generation.  Our  experiments  demonstrate 
that  DM  expression  can  antagonize  T  cell  recognition  of 
APCs.  A  second  observation  made  in  this  analysis  is  that 
DM  is able  to function  independently  of Ii  (groups  D  and 
E).  Several T  cells were  enhanced  or antagonized  by DM 
expression in cells that lacked Ii. Finally,  a few T  cells rec- 
oguized epitopes whose  expression was not measurably  af- 
fected by Ii or DM  expression  (group  F). 
We  were most intrigued by the finding that DM  expres- 
sion antagonized  the reactivity of so many T  cells (13 of 35 
the T  cells analyzed). Interestingly,  most of these T  cells re- 
quired  Ii to be  expressed  within  the  APC.  Thus,  the pep- 
tide(s)  recognized by  the  T  cells are  dependent  on  Ii,  and 
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Figure 3.  Summary  ofallorec- 
ognmon of l-Ad-posmve cells. A 
total of 35 m&wdual T cell hy- 
bndomas were screened for reac- 
t~vtty on L cell transfectants that 
vary only m the expression of It 
and DM. Supernatants of T cell- 
APC cultures were quantified for 
the presence of IL-2 and the data 
are presented as pmograms/ml of 
IL-2.  React]vtty patterns were 
tdennfied based on relanve reac- 
uwty  wtth  the  four types of L 
cells shown. Sample T  cells that 
represent  the  patterns observed 
are shown, as zs the number of T 
cells (of 35)  that &splayed a par- 
tlcular reacuvtty pattern. The re- 
activity patterns were the follow- 
mg  (A)  h  and  DM  are  both 
required to generate the epltope; 
(B) the epltope reqmres h, but is 
extmgmshed  by  addmonal  ex- 
pressrun of DM, (C) the ep]tope 
reqmres h and ts not measurably 
enhanced  by  further expression 
of DM; (D) ezther h or DM ex- 
pressed  alone increase epltope 
expression  relanve to  A  a  only; 
(E)  rather h  or  DM  expressed 
alone diminish the  epltope  ex- 
presslon relatxve to A  d only, (F) neither h or DM have any measurable effect on T cell recognmon, ln&v]dual T cells were tested at least twice with slm- 
llar results before assigning them to a parucular reacuwty pattern 
DM  apparently  diminishes  their  association  with  class  II 
molecules.  One of the obvious candidate peptides that would 
display  such  a  phenotype  is  the  Ii-derived  CLIP  peptide, 
which  binds  to  the  peptide-binding  pocket  of the  class  II 
molecule in the absence  of DM  (41,  42).  Biochemical  and 
serological  studies  have  shown  that  DM  catalyzes  the  re- 
lease  of CLIP  from  class  II  (17-19).  We  sought  to  deter- 
mine whether the T  cells whose recognition requires Ii and 
are antagonized by DM  are specific  for CLIP.  To  examine 
this,  we  attempted  to  stimulate  T  cells  with  I-Ad-positive 
APCs  cultured  w~th  high  concentrations  of synthetic pep- 
tides  corresponding  to  the  CLIP  segment.  Two  forms  of 
the  CLIP  peptide  were  tested:  a  peptide  corresponding  to 
amino  acids  86--102,  a  sequence  identical  to  the  major 
CLIP  segment  isolated  from  I-A  d  in  normal  B  cell  lines 
(22);  and  a  longer CLIP peptide,  corresponding  to  amino 
acads  81-105,  a  sequence  that  is  analogous  to  the  human 
CLIP  isolated  from  DM-negative  cells  (41,  42).  A a  cells 
were incubated with  100  ~M  CLIP peptide  and tested for 
their  ability  to  stimulate  T  cells  of group  B.  Fig.  4  shows 
that there was no gain  in reactivity by the presence  of the 
CLIP  peptide  in  culture.  These  data  support  the  idea  that 
the alloreactive  T  cells are not specific  for CLIP but rather 
a self peptide whose  association  with class  II,  like  CLIP,  xs 
diminished by DM.  This hypothesis is strengthened by our 
findings  that  DM-antagonized  T  cells  react  with  spleen 
cells from Ii-negative mice  (data not shown)  and is consis- 
tent  with  the  observations  made  with  the  DM-deficient 
mice,  which  show that CLIP-class  II  is not stimulatory  for 
alloreactive T  cells  (43). 
To  extend  these  studies  to  a  T  cell  whose  specificity  is 
known, we tested a T  cell hybridoma that is specific  for an 
La-derived  peptide  (amino  acids  61-85)  presented  in  the 
context ofA  a.  Previous studies by our laboratory have doc- 
umented  many  characteristics  of  this  presentation  event 
(23).  Cells  expressing  [Ad  +  Ii]  or  [Ad  +  Ii  +  DM]  were 
supertransfected  with  the  gene  encoding  H-2L  d and  then 
tested for their ability to stimulate the Ad-restricted Ld-spe - 
cific  T  cell  BC7.  Like  the  alloreactive  T  ceils  in  group  B 
and E, the epitope recognized by BC7 was dlmimshed dra- 
matically by the presence of DM within the APC  (Fig.  5). 
The studies presented in this paper point to the model in 
which both Ii and DM can act as either positive or negatwe 
regulators  of expression  of self-peptides in association  with 
the class  II molecule. A  namor fraction ofT  cells react opti- 
mally  in  the  absence  of both  cofactors,  and lose  reactwity 
when either one or both are expressed. It is likely that these 
peptides  bind  to  the  class  II  molecule  in  the  endoplasm]c 
reticulum,  where  Ii  has  been  shown  to  compete  for anti- 
genic  peptide  binding  (5).  Like  Ii,  DM  might  act  an  this 
compartment  to  remove such a peptide  or might  act later, 
within  the  low  pH  milieu  of the  endosomes.  In  contrast 
with  the  T  cells  who  lose  reactivity  in  the  presence  of Ii, 
the vast majority  of epitopes  recognized  by the  T  cells  are 
enhanced by the presence  of Ii within the APC.  For many 
of these,  DM  greatly enhances epitope  expression.  We an- 
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Figure  4.  CLIP  does not sen- 
smze  DM-antagonlzed  T  cells 
for  recognmon.  T  cells  from 
group  B  m  Fig.  3  were  cocul- 
tured with  L  cells  expressing A a 
alone  with  100  p~M  CLIP  pep- 
tide (corresponding to armno ac- 
ids  86-102  or  81-105,  as  indi- 
cated in the  figure). A d  +  11 and 
A a  +  h  +  DM  cells  were  also 
included  in  this  assay.  The  86- 
102 CLIP pepude was able to sen- 
smze  CLiP-specific  l-Ab-restncted 
T  cells (data not shown). 
ticipate  that  these  peptides  bind  to  the  class  II  molecule 
within  endocytic  compartments,  an  event  that  would  be 
enhanced by Ii, but that requires DM for CLIP removal or 
for accumulation of the peptide  on class  lI molecules.  The 
large  group of T  cells  that require  Ii but lose reactivity in 
the presence  of DM were the most unexpected.  Enhance- 
ment by Ii suggests an endosomal loading event, and antag- 
onism  by  DM  may  reflect  an  interaction  of the  peptide 
with  the  class  II molecule,  which is analogous to that dis- 
played  by  CLIP  itself.  In  vitro  studies  involving purified 
DM  and  DR  have  shown  that  at  low  pH,  DM  can  pro- 
mote dissociation of a non-CLIP peptide  (17).  One model 
for DM function is that it interacts directly with the class II, 
and stabilizes an open conformation of the peptide-binding 
pocket.  Such  a  conformation  would  allow  a  peptide  like 
CLIP to be released.  Peptides that are resistant to DM-cat- 
alyzed release might have distinctive binding characteristics 
that allow stable binding to the class II molecule even when 
it is in this alternative conformation. Thus, m  a DM-positive 
cell,  these  would  accumulate  preferentially  over less  stable 
binding peptides. 
In conclusion, we show here in an intact cell system that 
the  effects  of DM  on  antigenic  class  II-peptide  complex 
cell  surface  expression  can be  negative  as well  as positive. 
These findings point to the function  of DM within  APCs 
as  a  peptide-exchange  protein  that  can  either  increase  or 
decrease  expression  of peptide-MHC  class  II  complexes. 
Hence,  the  biological  effects  of DM  on antigen  presenta- 
tion clearly extend beyond removal of CLIP. The ultimate 
effect  of DM  on  accumulation  of peptlde-class  II  com- 
plexes will likely relate  to the biochemistry of the interac- 
tion with the class II molecule itself,  as well as the subcellu- 
lar site where  the peptide loads onto the class  II molecule. 
Of particular  note  in  this  regard  is  the  recent  observation 
by Jensen  and coworkers suggesting that  I-A  a may be  un- 
usually labile  at mildly acidic pH  (44).  This  property  may 
reflect a structural feature in this class II molecule that con- 
tributes  to  relatively  high  sensitivity  to  the  DM-mediated 
effects.  Finally,  our studies raise the interesting question of 
how DM-antagonized T  cells were generated  in response 
to a stimulator cell population that has the genetic capacity 
to  express  DM.  We  can  envision  at  least  two  possibilities. 
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First,  within the heterogeneous population of class II-positive 
spleen cells,  which include B  cells, macrophages, and den- 
dritic  cells,  there may some cell types that produce unusu- 
ally low levels of DM, relative to the class II restriction ele- 
ment.  These could be the cells  that originally activated the 
DM-antagonized T  cells.  We have not yet quantified DM 
protein levels in subpopulations of  APCs in the spleen or m 
the  L  cell  transfectants,  and we  do  not know  the  relative 
abundance of the source proteins from which the self pep- 
ndes recognized by the alloreactive T  cells  are derived. The 
finding  that  DM-mediated  antagonism  can  be  observed 
with  a  peptide  derived  from  H-2L  a,  whose  expression  is 
similar in L cells and in splenic APCs, argues that the nega- 
tive effects of DM on epitope expression observed in the L 
cells  do  not  require  low  levels  of antigen.  An  alternative 
possib|lity is that the intracellular  events that contribute  to 
DM function, such as pH of the endosomal compartments 
or the  dwell  time  of DM  with  the  class  II restriction  ele- 
ment, may vary from one cell type to another,  and may be 
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Figure  5.  Expression ofAd-L  d (61-85)  1s antagonized by DM  expres- 
sion within the APC. L  cells expressing A d +  11 or A d +  h  +  DM  were 
supertransfected with the gene encoding L a. Transfectants expressing L a at 
the  cell surface were tested for their abihty to activate BC7  (23).  Shown 
are  the  pIcograms/ml of IL-2 produced by BC7  in  response to the  two 
APCs. particularly active in subsets of cells in the spleen and in the 
fibroblasts that we have studied here.  Our finding that the 
function of DM is more complex than previously suspected 
will make  the  analysis of the  regulation  of its expression, 
biochemistry, and intracellular trafficking patterns particu- 
larly interesting. 
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